- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 287.62M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 287.52M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 94.35M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $651K |
| Capex restated | Q1 2024 · Mar 31, 2023 | $113K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$4.36M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$1.06M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $14.22M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $22.54M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$20.83M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$7.38M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $97.15M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $87.73M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $241.38M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $233.61M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $51.41M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $52.86M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $220.61M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $226.37M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.05 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.10 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.10 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $18.97M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $8.93M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$13.64M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$9.32M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$8.94M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$4.89M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $10.03M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $4.05M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $22.12M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $11.61M |
| Revenue | Q1 2024 · Mar 31, 2024 | $32.15M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $15.65M |